UK Accuses Drugmakers Of Anti-Competitive Agreements
Actavis illegally made monthly payments to Waymade to not enter the market for a generic hormone-replacement treatment and then charged the country's national health care provider excessive prices for the drug,...To view the full article, register now.
Already a subscriber? Click here to view full article